Do you want to read an article? Please log in or register.
Treatment pathways of lipid-lowering therapies in Germany 2016-2022
Further Publications
RECOMMENDED
Related content
RECOMMENDED
Lipid-Lowering Drugs
Improvement of retinal microvascular function after initiation of lipid-lowering therapy with PCSK9 inhibitors - An observational study
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Clin Lipidol
Nägele MP, Raemy Y, Kreysing L, Barthelmes J, Ruschitzka F, Flammer AJ, Sudano I
doi: 10.1016/j.jacl.2025.03.006
RECOMMENDED
Myocardial Infarction
Lesion-Level Effects of LDL-C-Lowering Therapy in Patients With Acute Myocardial Infarction: A Post Hoc Analysis of the PACMAN-AMI Trial
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol
Biccirè FG, Kakizaki R, Koskinas KC, Ueki Y, Häner J, Shibutani H, Lønborg J, Spitzer E, Iglesias JF, Otsuka T, Siontis GCM, Stortecky S, Kaiser C, Ambühl M, Morf L, Ondracek AS, van Geuns RJ, Spirk D, Daemen J, Mach F, Windecker S, Engstrøm T, Lang I, Losdat S, Räber L
doi: 10.1001/jamacardio.2024.3200
Heart Failure
Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode
ESC Heart Fail
Pollack CV Jr, Arroyo D, Kanda E, Lázaro IJS, Lesén E, Franzén S, Gray CM, Lipińska A, Murohara T, Rastogi A
doi: 10.1002/ehf2.15171
RECOMMENDED
Heart, Artery and Coronary Diseases
Long-Term Lipid Lowering With Evolocumab in Older Individuals
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
J Am Coll Cardiol
Al Said S, O'Donoghue ML, Ran X, Murphy SA, Atar D, Keech A, Flores-Arredondo JH, Wang B, Sabatine MS, Giugliano RP
doi: 10.1016/j.jacc.2024.11.019
Heart Failure
Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure
Eur J Heart Fail
Tomasoni D, Benson L, Gatti P, Villaschi A, Ljungman C, Metra M, Scorza R, Braunschweig F, Melin M, Rosano G, Böhm M, Butler J, Abraham WT, Mullens W, Gadler F, Linde C, Lund LH, Savarese G
doi: 10.1002/ejhf.3719
Heart, Artery and Coronary DiseasesTherapy and Intervention
Prospective study on the impact of different anti-thrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter aortic valves - The NOTION-4 trial: Anti-thrombotic therapy and TAV-HALT
Am Heart J
Thuraiaiyah J, Jørgensen TH, Jensen JM, Fuchs A, Willemen Y, Terkelsen CJ, Kofoed KF, Søndergaard L, Nørgaard B, De Backer O
doi: 10.1016/j.ahj.2024.10.002
RECOMMENDED
Cardiovascular Risk and Diseases
Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical Trials
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Obstet Gynecol
Nudy M, Aragaki AK, Jiang X, Manson JE, Shadyab AH, Jung SY, Martin LW, Wild RA, Womack C, Mouton CP, Rossouw JE, Schnatz PF
doi: 10.1097/AOG.0000000000005862
SPECIAL REPORT
Atrial Fibrillation
Considerations When Switching Direct Oral Anticoagulation Therapy in Patients with Non-Valvular Atrial Fibrillation
Heart, Artery and Coronary Diseases
Percutaneous coronary intervention plus medical therapy versus medical therapy alone in chronic coronary syndrome: a propensity score-matched analysis from the Swedish Coronary Angiography and Angioplasty Registry
Heart
von Koch S, Koul S, Grimfjärd P, Andersson J, Jernberg T, Omerovic E, Fröbert O, Erlinge D, A Mohammad M
doi: 10.1136/heartjnl-2024-324307